patient access partnership
ActiveSummary
For patient access partnership, at least two filing cycles of the annual accounts are missing. The 2021 annual accounts show equity of €18,365 and a net result of -€9,391. Its solvency ranks better than 82% of 1,538 sector peers (NACE 63, financial year 2021). The association has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is below 0.1% (very low).
Financials · financial year 2021, micro format
2022 annual accounts not yet filed, deadline passed on 31 July 2023 Financial year closed on 31 December 2022; filing due at the latest 7 months after the close (Companies Code art. 3:10). 4 financial years without a filing since the last one filed. Source: NBB filings, as of 14 October 2026.
2020 to 2021, 2 financial years
The operating result stays negative: a loss of €9,221 in 2021 against €30,053 in 2020; the loss shrinks.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 63, Computing infrastructure, data processing, hosting and other information service activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
| Line | 2020 | 2021 | Change |
|---|---|---|---|
| Gross operating margin9900 | €3,870 | €13,600 | ▲ 251% |
| Operating profit (loss)9901 | -€30,053 | -€9,221 | ▲ 69.3% |
| Recurring financial income75 | - | €5 | - |
| Recurring financial charges65 | €164 | €175 | ▲ 6.9% |
| Profit (loss) for the period before taxes9903 | -€30,217 | -€9,391 | ▲ 68.9% |
| Profit (loss) for the period9904 | -€30,217 | -€9,391 | ▲ 68.9% |
| Profit (loss) for the period to be appropriated9905 | -€30,217 | -€9,391 | ▲ 68.9% |
| Line | 2020 | 2021 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €42,637 | €22,052 | ▼ 48.3% |
| Current assets29/58 | €42,637 | €22,052 | ▼ 48.3% |
| Cash at bank and in hand54/58 | €42,637 | €22,052 | ▼ 48.3% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €42,637 | €22,052 | ▼ 48.3% |
| Equity10/15 | €27,755 | €18,365 | ▼ 33.8% |
| Profit (loss) carried forward14 | €27,755 | €18,365 | ▼ 33.8% |
| Amounts payable17/49 | €14,882 | €3,687 | ▼ 75.2% |
| Amounts payable within one year42/48 | €11,642 | €3,687 | ▼ 68.3% |
| Trade debts44 | €11,642 | €1,979 | ▼ 83.0% |
| Line | 2020 | 2021 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | -€30,217 | -€9,391 | ▲ 68.9% |
| Operating cash flow (approximation) | -€30,217 | -€9,391 | ▲ 68.9% |
| Change in cash | - | -€20,585 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2021 | micro format | 01-04-2022 | 2022-09600565 |
| 31-12-2020 | micro format | 23-07-2021 | 2021-38400449 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.